GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Change In Payables And Accrued Expense

American Vietnamese Biotech (HSTC:AMV) Change In Payables And Accrued Expense : ₫0.00 Mil (TTM As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Change In Payables And Accrued Expense?

American Vietnamese Biotech's Change In Payables And Accrued Expense for the quarter that ended in . 20 was ₫0.00 Mil. It means American Vietnamese Biotech's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

American Vietnamese Biotech's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was ₫0.00 Mil. It means American Vietnamese Biotech's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .


American Vietnamese Biotech Change In Payables And Accrued Expense Historical Data

The historical data trend for American Vietnamese Biotech's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Change In Payables And Accrued Expense Chart

American Vietnamese Biotech Annual Data
Trend
Change In Payables And Accrued Expense

American Vietnamese Biotech Quarterly Data
Change In Payables And Accrued Expense

American Vietnamese Biotech Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Vietnamese Biotech Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


American Vietnamese Biotech (HSTC:AMV) Business Description

Industry
Traded in Other Exchanges
N/A
Address
20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.

American Vietnamese Biotech (HSTC:AMV) Headlines

From GuruFocus

Atlis Motor Vehicles Reaches 2 Gigawatt-Hours in Customer Demand for Batteries

By Stock market mentor Stock market mentor 01-11-2023

Atlis Motor Vehicles to Present Strategies to Build and Expand Charging Infrastructure

By Stock market mentor Stock market mentor 01-19-2023